Previous close | 6.50 |
Open | 6.44 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 6.40 - 6.53 |
52-week range | 5.12 - 6.99 |
Volume | |
Avg. volume | 6,682 |
Market cap | 38.96M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.29 |
Earnings date | 15 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Discover how POCI achieved a record engineering revenue and improved financial metrics amidst strategic expansions and market challenges.
Conference Call Scheduled for today, May 15, 2024, at 5:00pm ETGARDNER, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024. Q3 2024 Financial Highlights (3 Months Ended March 31, 2024): Revenue increased 4% to $5.2 million, com
GARDNER, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system. The assembly draws on POC's unique micro-optics and digital imaging technologies. This is the largest order POC has ever received a